Sunday, May 31, 2026 | 07:24 PM ISTहिंदी में पढें
Titan Biotech Ltd
Board Meeting Intimation for Consideration & Approval Of The Audited (Standalone & Consolidated) Financial Results For The Quarter And Financial Year Ended March 31 2025 And Consideration Of Recommendation Of Final Dividend If Any For The Financial Year E
12:24 PM, 26th May 2025
Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited (Standalone and Consolidated) Financial Results for the Quarter and Financial Year ended March 31 2025 and to consider recommendation of Final Dividend if any for the Financial Year ended March 31 2025.